---
title: Integration of Î¶-deficient CARs into the CD3-zeta gene conveys potent cytotoxicity
  in T and NK cells
date: '2024-03-17'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38493479/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240318180743&v=2.18.0.post9+e462414
source: Blood
description: Chimeric antigen receptor (CAR)-redirected immune cells hold significant
  therapeutic potential for oncology, autoimmune diseases, transplant medicine, and
  infections. All approved CAR-T therapies rely on personalized manufacturing using
  undirected viral gene transfer, which results in non-physiological regulation of
  CAR-signaling and limits their accessibility due to logistical challenges, high
  costs and biosafety requirements. Random gene transfer modalities pose a risk of
  ...
disable_comments: true
---
Chimeric antigen receptor (CAR)-redirected immune cells hold significant therapeutic potential for oncology, autoimmune diseases, transplant medicine, and infections. All approved CAR-T therapies rely on personalized manufacturing using undirected viral gene transfer, which results in non-physiological regulation of CAR-signaling and limits their accessibility due to logistical challenges, high costs and biosafety requirements. Random gene transfer modalities pose a risk of ...